Skip to main content
Equibles
AMTX logo

AMTX · Aemetis, Inc

Track AMTX — free

Use AMTX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$1.83 +0.00 (+0.00%) At close · Sep 4
Russell 2000 member Rebalance outlook locked
Going-concern doubt — flagged Aug 6, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Notwithstanding our plans to improve liquidity and the favorable recent events described above, based on the extent of our debt and reliance on our senior secured lender, along with expected near-term shortfalls in cash flow from operations, substantial doubt exists about our ability to continue as a going concern over the next twelve months.”
View the 10-Q filed Aug 6, 2026
Market Cap
$132.07M
Shares
72.17M

AMTX metrics

70 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1.83
Market cap
$132.07M

Price action

19 metrics
Price change (1W)
-1.6%
Price change (30D)
+6.4%
Price change (3M)
-18.7%
Price change (6M)
+30.7%
Price change (YTD)
+31.7%
Price change (1Y)
-24.7%
Trailing year
Price change (5Y)
-84.9%
52-week high
$3.66
52-week low
$1.32
Change from 52-week high
-50.0%
Change from 52-week low
+38.6%
Annualized volatility
96.8%
Beta
0.9
RSI (14D)
51.5
Price vs SMA 50
+7.1%
Price vs SMA 200
-5.8%
Avg volume (3M)
1.05M
Relative volume
0.6
Average dollar volume
$1.83M

Company

3 metrics
Sector
Basic Materials
Industry
Specialty Chemicals
Shares outstanding
72.17M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
2.5×
reciprocal yield 40.2%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.6×
reciprocal yield 166.9%
P / book
—
FCF yield
-29.9%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-45.7%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
2.1×
reciprocal yield 47.8%
EV / revenue historical average (5Y)
2.3×
reciprocal yield 44.3%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
10.9%
Operating margin
-5.3%
Trailing 12 months
Net margin
-27.4%
Gross profit (TTM)
$23.94M
Operating profit (TTM)
−$11.55M
Net income (TTM)
−$60.16M
Trailing 12 months
Diluted EPS (TTM)
$-0.86
FCF margin
-17.9%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-4,056.41

Growth

11 metrics
Revenue growth YoY
+20.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$219.82M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+22.9%
Year over year · more shares
Revenue CAGR (3Y)
+91.6%
Revenue CAGR (5Y)
+3.6%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-20.8%
Debt / equity
—
Current ratio
0.1
EBITDA (TTM)
−$15.20M
Free cash flow (TTM)
−$39.33M
Quick ratio
0.0
Interest coverage
-0.2
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$414.92M
Latest balance sheet
Cash & equivalents
$973,000
Total assets
$289.18M
Total debt
$415.89M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$3.60M
Capital expenditures (TTM)
$35.73M
R&D (TTM)
$152,000
SG&A (TTM)
$35.49M
Stock compensation (TTM)
$4.91M
R&D / revenue
—
Stock compensation / revenue
2.2%

Ownership (13F)

3 metrics
13F filers
89
13F filer change QoQ
+11
Institutional ownership
25.1%

Short interest

3 metrics
Short interest
12.0%
Latest settlement · 11.0 days to cover
Days to cover
11.0d
Short-squeeze score
74 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$20,500
Insider-sentiment score
52 / 100

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 738214 CUSIP 00770K202 13F (30d) 65 filings 65 filers Visit website